PET imaging services firm Molecular Imaging of San Diego reported a dip in revenues for the company's first quarter of fiscal 2005 (end-September 30).
For the period, Molecular Imaging posted sales of $5 million, a drop of 11% compared to sales of $5.6 million in the same period of fiscal 2004. The company had a net loss for the first quarter of $458,000, compared to a net loss of $409,000 in the same period a year ago.
The company said that some $400,000 of the drop in revenue was due to customers electing to purchase FDG directly from third-party suppliers rather than including it in the price of service. Also, the firm said it took a $177,000 noncash impairment loss in the most recent period due to a lease restructuring with GE Healthcare of Waukesha, WI.
By AuntMinnie.com staff writers
November 23, 2004
Related Reading
Molecular Imaging taps CEO, posts 2004 loss, October 14, 2004
Molecular Imaging CEO resigns, September 20, 2004
Molecular Imaging, CCP sign distribution deal, August 24, 2004
Molecular Imaging nets Kaweah Delta, June 11, 2004
Molecular Imaging requests de-listing from Berlin exchange, June 11, 2004
Copyright © 2004 AuntMinnie.com